Your browser doesn't support javascript.
loading
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer.
Xu, Caili; Zhu, Min; Wang, Qian; Cui, Jiajun; Huang, Yuping; Huang, Xiting; Huang, Jing; Gai, Junwei; Li, Guanghui; Qiao, Peng; Zeng, Xian; Ju, Dianwen; Wan, Yakun; Zhang, Xuyao.
Afiliação
  • Xu C; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China.
  • Zhu M; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Wang Q; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China.
  • Cui J; Tanwei College, Tsinghua University, Beijing, 100084, China.
  • Huang Y; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Huang X; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China.
  • Huang J; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Gai J; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Li G; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Qiao P; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China.
  • Zeng X; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China.
  • Ju D; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China. dianwenju@fudan.edu.cn.
  • Wan Y; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, 201318, China. ykwan@novamab.com.
  • Zhang X; Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, 201203, China. xuyaozhang@fudan.edu.cn.
J Nanobiotechnology ; 21(1): 410, 2023 Nov 06.
Article em En | MEDLINE | ID: mdl-37932752

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoconjugados Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoconjugados Idioma: En Ano de publicação: 2023 Tipo de documento: Article